Etiologic Considerations in Peripheral Vascular Diseases of the Lower Extremity with Special Reference to Diabetes Mellitus
- 1 January 1966
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 33 (1) , 98-106
- https://doi.org/10.1161/01.cir.33.1.98
Abstract
A histopathologic and immunopathologic study of changes in small vessels has been carried out on 168 amputated lower extremities. No difference was found in respect to the frequency of thrombotic or atheromatous lesions among the various clinical disease categories necessitating amputation. An increased frequency of inflammatory lesions of small vessels was found only in cases of osteomyelitis. The frequency of hemodynamic lesions was highest in nondiabetic subjects with arteriosclerosis, and second highest in diabetic subjects with arteriosclerosis, followed by thromboangiitis obliterans. Proliferative endothelial lesions were encountered most frequently in diabetes with arteriosclerosis, in osteogenic sarcoma, and in osteomyelitis. Such proliferative lesions were encountered in 80 per cent of diabetic subjects and in 20 per cent of nondiabetic individuals. Fluorescent insulin binding by small vessels was found in 70 per cent of diabetic subjects with proliferative vascular lesions and in only 30 per cent of diabetic individuals without this proliferative microangiopathy. Such insulin binding was observed in 54 per cent of diabetic subjects and in only about 15 per cent of nondiabetic patients. The binding of fluorescent rabbit antihuman globulin was observed in 56 per cent of diabetic subjects and in 22 per cent of nondiabetic patients. These findings are discussed in relation to the thesis that there may be diseases of immune origin primarily involving small peripheral vessels. The peripheral vascular disease of diabetes is particularly stressed here because it is probably the most common form of such disease of immune origin. Such pathologic processes in small vessels may secondarily involve large cognate system arteries, either by creating an increased peripheral resistance to the flow of blood or when lesions involve the vasa vasorum, there may be impairment of local nutrition. Either or both of these phenomena could intensify the development of arteriosclerosis of large trunk arteries. Although no attempt has been made here to justify or negate the existence of thromboangiitis obliterans as a disease entity, it has been pointed out that at least some cases with this diagnosis may have a similar immune origin.This publication has 33 references indexed in Scilit:
- ANTIBODY-LIKE ACTIVITY IN DIABETIC AND NORMAL SERUM, MEASURED BY COMPLEMENT CONSUMPTIONThe Lancet, 1965
- Heart Muscle Antibodies in Rheumatic Fever and Other Diseases*Journal of Clinical Investigation, 1964
- INSULIN ANTIBODIESThe Lancet, 1963
- Occlusive Arterial Disease in Extremities, with Special Reference to Buerger's DiseaseAngiology, 1962
- Amelioration of Diabetes Mellitus Following Gastric ResectionActa Medica Scandinavica, 1961
- The Gastric Mucosa in Diabetes MellitusActa Medica Scandinavica, 1961
- HEART-SPECIFIC AUTOANTIBODIESThe Lancet, 1960
- CEREBRAL THROMBOANGIITIS OBLITERANSMedicine, 1957
- VASCULAR CHANGES IN DIABETES WITH PARTICULAR REFERENCE TO THE RETINAL VESSELS: Preliminary ReportBritish Journal of Ophthalmology, 1949
- Clinical and Pathologic Observations with Special Reference to Doubly Refractile Fatty Cells and Casts in the UrineMedicine, 1948